Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea

INTRODUCTION: Globally, pneumococcal disease represents a significant burden. South Korea implemented the 7-valent pneumococcal conjugate vaccine (PCV7) in 2003, replaced with the 10-valent (PCV10) and 13-valent (PCV13) vaccine in 2010. In 2014, both vaccines were introduced in the national immuniza...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hum Vaccin Immunother
Главные авторы: Kim, Hye-Young, Park, Seong-Beom, Kang, Eun-Sil, Lee, Sang-Min, Kim, Hyun-Jin, Wasserman, Matt
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2020
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993233/
https://ncbi.nlm.nih.gov/pubmed/32783576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1796426
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы